Steadybase.

Hinge Health, Inc.

Website Investor relations LinkedIn Latest 10-K
  • HNGE · NYSE
  • Services-Computer Processing & Data Preparation
  • San Francisco, CA
  • 1,437 employees
  • CIK 0001673743

Updated from SEC filings through

Top things to know

Executives

What leadership is saying

“Our strong performance continues to reflect our ability to deliver exceptional clinical outcomes, a better healthcare experience and lower client costs at scale”

Daniel Perez, Co-Founder and CEO, Hinge Health
Earnings press release (8-K Ex. 99.1), filed November 2, 2026

Hinge Health, Inc. is a U.S. public company in services-computer processing & data preparation (SIC 7374), headquartered in San Francisco, CA. It trades as HNGE on NYSE. Revenue was $588M in the fiscal year ending December 31, 2025, +50.6% from the year before. It reported about 1,437 employees. Daniel Perez is Co-Founder and CEO, Hinge Health.

Five-year financials

MetricFY2025FY2024FY2023
Revenue $588M
10-K, 2026-03-03
$390M
10-K, 2026-03-03
$293M
10-K, 2026-03-03
Operating income -$546M
10-K, 2026-03-03
-$31.9M
10-K, 2026-03-03
-$131M
10-K, 2026-03-03
SG&A $646M
10-K, 2026-03-03
$231M
10-K, 2026-03-03
$215M
10-K, 2026-03-03
Net income -$528M
10-K, 2026-03-03
-$11.9M
10-K, 2026-03-03
-$108M
10-K, 2026-03-03

Annual figures from XBRL in each company's own filings. Click a figure to open the filing. SG&A marked derived is general and administrative plus selling and marketing.

Leadership and board

NameTitleSource
Daniel Perez Co-Founder and CEO, Hinge Health 8-K, 2026-11-02
Daniel Antonio Perez CEO & Co-Founder 4, 2026-09-11
James Budge
Chief Financial Officer at Hinge Health
Chief Financial Officer 4, 2026-09-11
James Pursley President 4, 2026-09-23

What Hinge Health, Inc. does

Hinge Health leverages software, including AI, to automate care for joint and muscle health, delivering an outstanding member experience, improved member outcomes, and cost reductions for our clients and members. We have designed our platform to address a broad spectrum of MSK care—from acute injury, to chronic pain, to post-surgical rehabilitation.

Item 1. Business, 10-K for the year ending December 31, 2025

Shares and governance

Public float $1.5B (as of June 30, 2025) 10-K, March 3, 2026
Reportable segments 1 (period ending September 30, 2026) 10-Q, November 9, 2026
Latest proxy statement Meeting June 3, 2026 (filed April 17, 2026) DEF 14A, April 17, 2026
Auditor Deloitte & Touche LLP (San Francisco, California) Latest 10-K

Insider trades

Open-market buys and sales by officers and directors, from Forms 4 and 5. One row per filing.

DateInsiderTradeSharesValueSource
October 12, 2026 Gabriel M.I. Mecklenburg
Director
Sale 200,000 $20.6M Form 4, October 13, 2026
October 12, 2026 James Budge
Chief Financial Officer
Sale 47,720 $4.9M Form 4, October 13, 2026
October 6, 2026 Daniel Antonio Perez
CEO & Co-Founder
Sale 4,100 $411K Form 4, October 7, 2026
September 21, 2026 James Pursley
President
Sale 33,000 $3.1M Form 4, September 23, 2026
September 14, 2026 Gabriel M.I. Mecklenburg
Director
Sale 150,000 $14.0M Form 4, September 15, 2026
September 11, 2026 Gabriel M.I. Mecklenburg
Director
Sale 250,000 $22.2M Form 4, September 14, 2026
September 10, 2026 Daniel Antonio Perez
CEO & Co-Founder
Sale 250,000 $22.4M Form 4, September 11, 2026
September 10, 2026 James Budge
Chief Financial Officer
Sale 55,561 $5.0M Form 4, September 11, 2026

Recent 8-K events

  • 8-K filed 2026-11-02
    • Item 2.02 Results of operations and financial condition (earnings release)
    • Item 5.02 Departure or appointment of directors or officers; compensation
    • Item 7.01 Regulation FD disclosure
  • 8-K filed 2026-08-21
    • Item 1.01 Entry into a material definitive agreement
    • Item 2.03 Creation of a direct financial obligation
  • 8-K filed 2026-08-04
    • Item 2.02 Results of operations and financial condition (earnings release)
    • Item 7.01 Regulation FD disclosure
    • Item 8.01 Other events
  • 8-K filed 2026-06-09
    • Item 7.01 Regulation FD disclosure
  • 8-K filed 2026-06-04
    • Item 5.07 Submission of matters to a vote of security holders
  • 8-K filed 2026-05-05
    • Item 2.02 Results of operations and financial condition (earnings release)
    • Item 7.01 Regulation FD disclosure
  • 8-K filed 2026-03-17
    • Item 5.02 Departure or appointment of directors or officers; compensation
  • 8-K filed 2026-02-10
    • Item 2.02 Results of operations and financial condition (earnings release)
    • Item 7.01 Regulation FD disclosure
  • 8-K filed 2025-11-12
    • Item 7.01 Regulation FD disclosure
    • Item 8.01 Other events
  • 8-K filed 2025-11-04
    • Item 2.02 Results of operations and financial condition (earnings release)
    • Item 7.01 Regulation FD disclosure

Frequently asked questions about Hinge Health, Inc.

What does Hinge Health, Inc. do?
Hinge Health, Inc. is classified by the SEC as Services-Computer Processing & Data Preparation (SIC 7374). It is based in San Francisco, CA.
What is Hinge Health, Inc.'s revenue?
$588M for the fiscal year ending December 31, 2025, from its 10-K filed March 3, 2026.
Is Hinge Health, Inc. profitable?
Hinge Health, Inc. reported net income of -$528M for the fiscal year ending December 31, 2025.
How many employees does Hinge Health, Inc. have?
About 1,437 as of December 31, 2025, as stated in its annual report.
Who is the CEO of Hinge Health, Inc.?
Daniel Perez, Co-Founder and CEO, Hinge Health, as named in a 8-K filed November 2, 2026.
Who is the CFO of Hinge Health, Inc.?
James Budge, Chief Financial Officer, as named in a 4 filed September 11, 2026.
Where is Hinge Health, Inc. headquartered?
San Francisco, CA.
What is Hinge Health, Inc.'s stock ticker?
HNGE on NYSE.
What industry is Hinge Health, Inc. in?
Services-Computer Processing & Data Preparation, SIC code 7374.
What is Hinge Health, Inc.'s website?
hingehealth.com. Investor relations: https://ir.hingehealth.com/overview/default.aspx.
When does Hinge Health, Inc. report earnings next?
January 31, 2027. Source: estimate_8k_pattern.
Is Hinge Health, Inc. a public company?
Yes. Hinge Health, Inc. files with the SEC under CIK 0001673743 and trades as HNGE.
Who audits Hinge Health, Inc.?
Deloitte & Touche LLP, San Francisco, California, as named in its latest annual report (10-K).
What is Hinge Health, Inc.'s public float?
$1.5B as of June 30, 2025, as reported on the cover of its 10-K filed March 3, 2026.
How many business segments does Hinge Health, Inc. report?
1 reportable segment for the period ending September 30, 2026, from its 10-Q filed November 9, 2026.
When is Hinge Health, Inc.'s annual shareholder meeting?
June 3, 2026, per its proxy statement (DEF 14A) filed April 17, 2026.
Have Hinge Health, Inc. insiders traded stock recently?
Since May 11, 2026, officers and directors reported 19 open-market sales worth about $119M and 0 purchases on Forms 4 and 5. The most recent: Gabriel M.I. Mecklenburg (Director) sold 200,000 shares on October 12, 2026.